Andres E. Virchis

Wellhouse Lane
Barnet, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 15 publications

Myeloproliferative neoplasms with concomitant chronic myeloid leukemia are associated with TKI resistance and poor outcomes.

Myeloproliferative neoplasms with concomitant chronic myeloid leukemia are associated with TKI resistance and poor outcomes.

Journal: Leukemia

Published: November 06, 2025

Expectations and outcomes of varying treatment strategies for CML presenting during pregnancy.

Expectations and outcomes of varying treatment strategies for CML presenting during pregnancy.

Journal: British journal of haematology

Published: March 27, 2024

Ibrutinib as first-line therapy for mantle cell lymphoma: a multicenter, real-world UK study.

Ibrutinib as first-line therapy for mantle cell lymphoma: a multicenter, real-world UK study.

Journal: Blood advances

Published: July 14, 2023

Thrombotic microangiopathy in untreated myeloma patients receiving carfilzomib, cyclophosphamide and dexamethasone on the CARDAMON study.

Thrombotic microangiopathy in untreated myeloma patients receiving carfilzomib, cyclophosphamide and dexamethasone on the CARDAMON study.

Journal: British journal of haematology

Published: December 24, 2020

The addition of bendamustine to brentuximab vedotin leads to improved rates of complete metabolic remission in children, adolescents and young adults with relapsed and refractory classical Hodgkin lymphoma: a retrospective single-centre series.

The addition of bendamustine to brentuximab vedotin leads to improved rates of complete metabolic remission in children, adolescents and young adults with relapsed and refractory classical Hodgkin lymphoma: a retrospective single-centre series.

Journal: British journal of haematology

Published: November 17, 2020

Recurrent activating STAT5B N642H mutation in myeloid neoplasms with eosinophilia.

Recurrent activating STAT5B N642H mutation in myeloid neoplasms with eosinophilia.

Journal: Leukemia

Published: September 21, 2018

RNA-seq of newly diagnosed patients in the PADIMAC study leads to a bortezomib/lenalidomide decision signature.

RNA-seq of newly diagnosed patients in the PADIMAC study leads to a bortezomib/lenalidomide decision signature.

Journal: Blood

Published: May 09, 2018

Ofatumumab is a feasible alternative anti-CD20 therapy in patients intolerant of rituximab.

Ofatumumab is a feasible alternative anti-CD20 therapy in patients intolerant of rituximab.

Journal: British journal of haematology

Published: January 25, 2018

Polonium-210 poisoning: a first-hand account.

Polonium-210 poisoning: a first-hand account.

Journal: Lancet (London, England)

Published: July 28, 2016

A retrospective comparison of toxicity and initial efficacy of two autologous stem cell transplant conditioning regimens for relapsed lymphoma: LEAM and BEAM.

A retrospective comparison of toxicity and initial efficacy of two autologous stem cell transplant conditioning regimens for relapsed lymphoma: LEAM and BEAM.

Journal: Bone marrow transplantation

Published: May 24, 2016

Autologous stem cell transplantation outcomes in elderly patients with B cell Non-Hodgkin Lymphoma.

Autologous stem cell transplantation outcomes in elderly patients with B cell Non-Hodgkin Lymphoma.

Journal: British journal of haematology

Published: March 14, 2015

Autologous stem cell transplantation for follicular lymphoma is of most benefit early in the disease course and can result in durable remissions, irrespective of prior rituximab exposure.

Autologous stem cell transplantation for follicular lymphoma is of most benefit early in the disease course and can result in durable remissions, irrespective of prior rituximab exposure.

Journal: British journal of haematology

Published: September 11, 2013

Showing 1-12 of 15

Last Updated: 09/26/2026